CTBP2 contributes to cisplatin resistance in lung adenocarcinoma by inhibiting generation of reactive oxygen species
Mingqun Wang(Second People’s Hospital of Yibin), Chunsheng Hu(Chongqing University)
Cited by 1
Related Papers
LMNA Reduced Acquired Resistance to Erlotinib in NSCLC by Reversing the Epithelial–Mesenchymal Transition via the FGFR/MAPK/c-fos Signaling Pathway
|International Journal of Molecular Sciences|2022|19